Determine exogenous human DDAH2 gene function in rabbit bone marrow-derived endothelial progenitor cells in vitro

Area of Science:

• Cell Biology
• Regenerative Medicine
• Gene Therapy

Background:

• In vitro amplification of endothelial progenitor cells (EPCs) is crucial for gene transfer and regenerative medicine.
• Manipulation of EPCs for therapeutic purposes requires efficient isolation and genetic engineering techniques.

Purpose of the Study:

• To isolate and characterize rabbit bone marrow-derived EPCs.
• To successfully overexpress the dimethylarginine dimethylaminohydrolase 2 (DDAH2) gene in EPCs.
• To evaluate the feasibility of using these engineered EPCs for in vitro studies.

Main Methods:

• Isolation and culture of rabbit bone marrow-derived EPCs.
• Characterization of EPCs using immunocytochemistry and flow cytometry for surface markers (CD106, Flk-1, vWF, CD34).
• Transfection of EPCs with a plasmid vector expressing human DDAH2, followed by assays for proliferation, DDAH activity, and citrulline production.

Main Results:

• Isolated cells exhibited typical EPC morphology and confirmed expression of key surface markers.
• Successful overexpression of DDAH2 in EPCs (DDAH2-EPCs) was achieved.
• DDAH2-overexpressing EPCs showed significantly increased citrulline production compared to controls (235.34 ± 0.69 vs 95.26 ± 5.76 ng/mL, P = .023).

Conclusions:

• A reliable method for isolating and identifying EPCs from rabbit bone marrow was established.
• Efficient genetic engineering of EPCs to overexpress exogenous genes, specifically DDAH2, is feasible.
• This study provides a foundation for constructing hybrid structures of EPCs and genes like DDAH2 for in vitro functional analysis.